You are here

Zelboraf

Pfizer's Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028

Biopharma Reporter

Thu, 03/21/24 - 11:37 am

FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma

Pharmaceutical Business Review

Mon, 08/3/20 - 10:33 am

AACR: Roche's Tecentriq, added to Cotellic and Zelboraf, stalls melanoma progression

Fierce Pharma

Mon, 04/27/20 - 09:47 am

FDA approves Genentech's Cotellic as part of melanoma combo

BioPharma Dive

Wed, 11/11/15 - 09:28 pm

Roche and Exelixis roll toward FDA approval with a melanoma cocktail

Fierce Biotech

Thu, 02/19/15 - 10:41 am

Roche submits NDA for skin cancer med

Seeking Alpha

Mon, 12/15/14 - 11:09 am

Melanoma Treatment Battle Between Roche And GSK Heats Up

Bidness Etc.

Tue, 09/30/14 - 06:27 pm

Study: GlaxoSmithKline's Mekinist, Tafinlar combination shows survival benefit versus Roche's Zelboraf in melanoma

First Word Pharma

Thu, 07/17/14 - 10:12 am

Should Roche Buy Exelixis?

Motley Fool

Thu, 07/17/14 - 08:54 am

Roche, Exelixis Skin Cancer Drug Delays Tumor Progression

TheStreet.com

Mon, 07/14/14 - 10:32 am

Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy

Seeking Alpha

Thu, 12/5/13 - 06:43 pm

Bristol-Myers Squibb

Largest cancer gene database made public

Reuters

Tue, 07/16/13 - 11:20 am

Yervoy-Zelboraf combo trial stopped on toxicity worries

Fierce Pharma

Thu, 04/4/13 - 02:05 pm

Bristol-Myers Squibb

Genentech takes Exelixis drug into Phase III melanoma trial

Bizjournals.com

Thu, 01/17/13 - 10:19 am

Report: Roche's Zelboraf, BMS' Yervoy control their segment

Fierce Pharma

Fri, 09/21/12 - 01:13 pm

Bristol-Myers Squibb

Roche’s Skin Cancer Treatment Delayed By U.K. Drug-Cost Agency

Bloomberg

Fri, 08/10/12 - 10:09 am

Yervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share

Seeking Alpha

Tue, 07/24/12 - 11:25 pm

Bristol-Myers Squibb

Roche’s Zelboraf Fails To Win U.K. Drug-Cost Agency Backing

Bloomberg

Fri, 06/15/12 - 10:08 am

New Zelboraf data shows big survival boost

Fierce Pharma

Fri, 02/24/12 - 11:25 am

Roche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says

Bloomberg

Wed, 01/18/12 - 05:59 pm

Pages